NUMBERS,PEPTIDE,DRUG_NAME,AA_MUTATION,TRANSCRYPT
0,KWEMERTDITMKHKVGGGQYGEVYEGVWK,Imatinib,p.L267V,P00519-2
1,RTDITMKHKLGGGQHGEVYEGVWKKYSLT,Imatinib,p.Y272H,P00519-2
2,DITMKHKLGGGQYGVVYEGVWKKYSLTVA,Imatinib,p.E274V,P00519-2
3,LLGVCTREPPFYIIIEFMTYGNLLDYLRE,Imatinib,p.T334I,P00519-2
4,DITMKHKLGGGQYGKVYEGVWKKYSLTVA,Imatinib,p.E274K,P00519-2
5,AVVLLYMATQISSATEYLEKKNFIHRDLA,Imatinib,p.M370T,P00519-2
6,ENHLVKVADFGLSRMMTGDTYTAHAGAKF,Imatinib,p.L406M,P00519-2
7,RTDITMKHKLGGGQFGEVYEGVWKKYSLT,Imatinib,p.Y272F,P00519-2
8,PNYDKWEMERTDITVKHKLGGGQYGEVYE,Imatinib,p.M263V,P00519-2
9,EMERTDITMKHKLGEGQYGEVYEGVWKKY,Imatinib,p.G269E,P00519-2
10,TQISSAMEYLEKKNVIHRDLAARNCLVGE,Imatinib,p.F378V,P00519-2
11,PYPGIDLSQVYELLAKDYRMERPEGCPEK,Imatinib,p.E472A,P00519-2
12,MRACWQWNPSDRPSSAEIHQAFETMFQES,Imatinib,p.F505S,P00519-2
13,TQISSAMEYLEKKNCIHRDLAARNCLVGE,Imatinib,p.F378C,P00519-2
14,GVCTREPPFYIITELMTYGNLLDYLRECN,Imatinib,p.F336L,P00519-2
15,KKYSLTVAVKTLKEGTMEVEEFLKEAAVM,Imatinib,p.D295G,P00519-2
16,ERTDITMKHKLGGGHYGEVYEGVWKKYSL,Imatinib,p.Q271H,P00519-2
17,AFGVLLWEIATYGMCPYPGIDLSQVYELL,Imatinib,p.S457C,P00519-2
18,FGLSRLMTGDTYTAPAGAKFPIKWTAPES,Imatinib,p.H415P,P00519-2
19,ENHLVKVADFGLSRFMTGDTYTAHAGAKF,Imatinib,p.L406F,P00519-2
20,FGLSRLMTGDTYTARAGAKFPIKWTAPES,Imatinib,p.H415R,P00519-2
21,LLGVCTREPPFYIINEFMTYGNLLDYLRE,Imatinib,p.T334N,P00519-2
22,SLTVAVKTLKEDTMAVEEFLKEAAVMKEI,Imatinib,p.E298A,P00519-2
23,LYMATQISSAMEYLGKKNFIHRDLAARNC,Imatinib,p.E374G,P00519-2
24,IKWTAPESLAYNKFYIKSDVWAFGVLLWE,Imatinib,p.S436Y,P00519-2
25,LSQVYELLEKDYRMGRPEGCPEKVYELMR,Imatinib,p.E478G,P00519-2
26,KKYSLTVAVKTLKENTMEVEEFLKEAAVM,Imatinib,p.D295N,P00519-2
27,TQISSAMEYLEKKNIIHRDLAARNCLVGE,Imatinib,p.F378I,P00519-2
28,GVCTREPPFYIITEVMTYGNLLDYLRECN,Imatinib,p.F336V,P00519-2
29,LSQVYELLEKDYRMKRPEGCPEKVYELMR,Imatinib,p.E478K,P00519-2
